Major Recapitalization of Apex Dental Laboratory Group by LongueVue Capital Announced by BGL

Apex Dental Laboratory Group's Major Recapitalization

In a significant move aimed at bolstering its position in the dental industry, Brown Gibbons Lang & Company (BGL), a prominent investment banking and financial advisory firm, has announced the majority recapitalization of Apex Dental Laboratory Group (Apex). This recapitalization is being facilitated by LongueVue Capital, a private equity firm based in New Orleans, and Swaney Group Capital from Tampa. Though details on the deal have not been fully disclosed, it marks a pivotal step for Apex, which operates 16 labs across 10 states.

About Apex Dental Laboratory Group

Founded in 2015 and headquartered near Dallas, Texas, Apex Dental Laboratory Group has distinguished itself by providing dentists nationwide with high-quality dental solutions. These include fixed bridges, dental implants, crowns, removable dentures, and specialized pediatric dental products. Apex is particularly known for its branded innovations like Kinder Krowns, Lumineers, and Snap-On Smile, along with its digital platform, SurgicalGuides.com. A notable achievement for Apex was the introduction of the first 3D printed crown specifically for children in 2024, a landmark in pediatric dentistry.

In recent years, Apex has significantly expanded its operations through three new facilities and 22 acquisitions, positioning itself uniquely in the market with all of its products manufactured in the United States. This domestic manufacturing commitment resonates strongly with its core values and mission.

Commitment to Quality and Partnership

The entire management team at Apex will continue to lead the company, collaborating with industry veteran Billy Braun, who will stepping into the role of Executive Chairman. Braun is recognized for his previous role as CEO and President of DDS Lab, a major player in the dental laboratory space.

Kay Hayden, President and Co-Founder of Apex, emphasized that the company’s core values and its dedication to American manufacturing have formed the backbone of its success. He praised BGL for providing substantial support throughout the sale process, ensuring that their interests remained prioritized while identifying partners that aligned with Apex’s mission.

Travis Zick, another Co-Founder of Apex, echoed these sentiments, highlighting how BGL worked diligently to position their company favorably in the market, seeking out the best possible partnerships to support Apex's strategic goals.

The Role of BGL and Future Prospects

Jonathan Bluth, Managing Director at BGL, expressed his excitement in supporting Apex in unlocking its value and watching its growth trajectory flourish with the newly formed alliance with LongueVue and Swaney Group Capital. He is optimistic that this partnership will usher in new resources and creative strategies to further propel Apex into a promising future.

BGL's Healthcare and Life Sciences investment banking team, which specializes in advising companies in the healthcare sector, served as the exclusive financial advisor in this transaction. Their expertise in navigating complex mergers and acquisitions has positioned them as a trusted ally for Apex.

Conclusion

With this recapitalization, Apex is poised to enhance its operational capabilities and expand its outreach in the dental market further. As they continue to deliver high-quality, American-made dental products and services, the consolidation under LongueVue Capital and Swaney Group will potentially set a new standard in the industry. The partnership reflects a strategic alignment of values and vision, ensuring that Apex remains committed to its mission of providing excellent dental care while fostering growth in the years to come.

For detailed insights and updates on this transaction and more about Apex Dental Laboratory Group, visit BGL's website.